[ATSDR] National Amyotrophic Lateral Sclerosis (ALS) Registry
Revision of a currently approved collection
No
Regular
05/12/2026
table that charts list comparision
Requested
Previously Approved
36 Months From Approved
05/31/2026
11,549
11,649
1,757
1,763
0
0
As mandated by Congress, the goal is to continue collecting data for the National Amyotrophic Lateral Sclerosis (ALS) Registry to better describe the incidence and prevalence of ALS and to identify risk factors for the disease. ATSDR endeavors to improve the completeness, representativeness, and accuracy of the Registry data over time. This change request involves minor changes to a consent form and addition of incentives. In this revision, as required by the E.O., all use of the term "gender" has been replaced with "sex."
This revision request for PRA clearance aims to enhance the National ALS Registry's value for researchers. Key updates include: expanding the consent form to allow interagency data exchange with Unite Genomics, updating terminology from "gender" to "sex" as required by the EO, and revising biorepository consent and research application forms to clarify genomic data sharing, cell line use, and sample details. This collection is seeking 1751 annual burden hours for three years of approval.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.